Abstract
Recently there has been a noticeable resurgence in the usage of percutaneous balloon aortic valvuloplasty (BAV) by the development of less invasive endovascular therapies including transcatheter aortic valve implantation (TAVI). We performed BAV in a 91-year-old man with end-stage severe symptomatic aortic stenosis (AS) and an impending abdominal aortic aneurysm (AAA) rupture who had been refused surgical treatment because of the comorbidities with stage V chronic kidney disease (CKD) and severe left ventricular dysfunction. Improvement in hemodynamics and kidney function was observed after BAV. Subsequently, we performed endovascular aneurysm repair (EVAR) successfully for AAA using iodinated contrast. No deterioration of kidney function was confirmed after the procedure. The patient was discharged without any adverse events. At present, the possibilities of TAVI or surgical aortic valve replacement (s-AVR) are under consideration as the definitive therapy for the upcoming aortic valve restenosis. In conclusion, this inoperable patient with multiple comorbidities was successfully treated, at lower risk, by catheter-based two-stage therapy.
Similar content being viewed by others
References
Lindroos M, Kupari M, Heikkila J, Tilvis R (1993) Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 21:1220–1225
Kolh P, Kerzmann A, Lahaye L, Gerard P, Limet R (2001) Cardiac surgery in octogenarians: peri-operative outcome and long-term results. Eur Heart J 22:1235–1243
Saia F, Marrozzini C, Moretti C, Ciuca C, Taglieri N, Bordoni B, Dall’ara G, Alessi L, Lanzillotti V, Bacchi-Reggiani ML, Branzi A, Marzocchi A (2011) The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. EuroIntervention 7(6):723–729
Matsue Y, Matsumura A, Abe M, Ono M, Seya M, Nakamura T, Iwatsuka R, Mizukami A, Setoguchi M, Nagahori W, Ohno M, Suzuki M, Hashimoto Y (2010) Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients. Heart Vessels 25(4):306–312
Matejka J, Varvarovsky I, Vojtisek P, Herman A, Rozsival V, Borkova V, Kvasnicka J (2010) Prevention of contrast-induced acute kidney injury by theophylline in elderly patients with chronic kidney disease. Heart Vessels 25(6):536–542
Percutaneous balloon aortic valvuloplasty: acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. (1991). Circulation 84:2383–2397
Pedersen WR, Klaassen PJ, Boisjolie CR, Pierce TA, Harris KM, Lesser JR, Hara H, Mooney MR, Graham KJ, Kshettry VR, Goldenberg IF, Priztker MR, Van Tassel RA, Schwartz RS (2007) Feasibility of transcatheter intervention for severe aortic stenosis in patients ≥90 years of age: aortic valvuloplasty revisited. Catheter Cardiovasc Interv 70(1):149–154
Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux J, Pavie A, Gueret P, and on behalf of the FRANCE Registry Investigators (2011) FRANCE Registry Investigators. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 32(2):191–197
Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ, PARTNER Trial Investigators (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198
Babaliaros VC, Liff D, Chen EP, Rogers JH, Brown RA, Thourani VH, Guyton RA, Lerakis S, Stillman AE, Raggi P, Cheesborough JE, Veledar E, Green JT, Block PC (2008) Can balloon aortic valvuloplasty help determine appropriate transcatheter aortic valve size? JACC Cardiovasc Interv 1(5):580–586
Babaliaros VC, Junagadhwalla Z, Lerakis S, Thourani V, Liff D, Chen E, Vassiliades T, Chappell C, Gross N, Patel A, Howell S, Green JT, Veledar E, Guyton R, Block PC (2010) Use of balloon aortic valvuloplasty to size the aortic annulus before implantation of a balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv 3(1):114–118
Agarwal A, Kini AS, Attanti S, Lee PC, Ashtiani R, Steinheimer AM, Moreno PR, Sharma SK (2005) Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59–104 years. Am J Cardiol 95(1):43–47
Acknowledgments
The authors certify that they comply with the Principles of Ethical Publishing in the International Journal of Cardiology.
Conflict of interest
There is no conflict of interest in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Furuta, A., Shimizu, H., Hachiya, T. et al. Time to revisit role of transcatheter balloon aortic valvuloplasty: a bridge-therapy to subsequent treatment case report. Heart Vessels 28, 397–400 (2013). https://doi.org/10.1007/s00380-012-0268-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-012-0268-z